Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriersT.C. van Sprundel, Rob A.�E.�M. Tollenaar, Richard M. Brohet et al.|British Journal of Cancer|2005Cited by 291
Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS)Nadine Andrieu, Jenny Chang‐Claude, David E. Goldgar et al.|JNCI Journal of the National Cancer Institute|2006Cited by 233
A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical PracticeSusanne Rebers, Marjanka K. Schmidt, Eric Vermeulen et al.|PLoS ONE|2016Cited by 8
Use of oral contraceptives and risk of breast cancer in BRCA1/2 mutation carriersM.A. Rookus, DE Goldgar, Niklas Loman et al.|European Journal of Cancer Supplements|2004Cited by 1